Clinical Trial VICCTHO0967


Lung Cancer Mutation Consortium Protocol

Principal Investigator(s)

Leora Horn


  • Protocol No. VICCTHO0967
  • Open Date: 07/27/2010
  • Staging: NA
  • Age Group: Adults
  • Scope: National
  • Objective: To determine the frequency of oncogenic mutations in 3000 patients with advanced adenocarcinoma of the lung To study the associations between each mutation and clinical outcomes, e.g., survival, clinical features, e.g., smoking status, age, and other mutation. To characterize prognostic markers and identify new targets.
  • Disease Sites:
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01014286
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.